Long Angle is a private, vetted global community of accomplished entrepreneurs, executives, and professionals who have reached meaningful financial milestones and want to navigate wealth with peers who understand their challenges, opportunities, responsibilities, and ambitions.
Hosted by the founders of the Long Angle community, Navigating Wealth is a podcast for founders, executives, and investor operators who have built significant wealth. Each episode features a guest with an unusual career journey and deep expertise across some aspect of the economy, investing, family, health, or lifestyle.
Today we're thrilled to welcome Eric Green, M.D., Ph.D., CEO and Co-Founder of Trace Neuroscience. Eric is a physician-scientist and entrepreneur who has spent over a decade building genetics-focused biotech companies, including MyoKardia and Maze Therapeutics. At Trace, he's developing the first targeted genomic medicine for ALS in nearly a century, using human genetic insights to restore a critical protein that enables nerve-muscle communication.
Key Topics Covered:
• How sequencing thousands of human genomes reveals which genes matter for disease
• Why people with ALS lose the same protein that makes worms uncoordinated
• How genetic medicines work at the molecular level to target specific RNA
• The role of contract manufacturers in enabling biotech innovation
• Designing clinical trials for severe diseases where patients only get one chance
• Lessons from COVID-19 on balancing speed and safety in drug development
• The economics of drug pricing and why generics matter for long-term affordability
Links:
• Trace Neuroscience: https://traceneuro.com
• Daily Body Coach: dailybodycoach.com/navigatingwealth
• Apply to join Long Angle's Community: https://www.longangle.com/apply-now-nw
